Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology

Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity... see more

Add To Watchlist

Recent & Breaking News (NDAQ:TCRT)

ZIOPHARM to Hold Second Quarter 2016 Financial Results Conference Call and Webcast on Tuesday, August 9, 2016

GlobeNewswire August 2, 2016

SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of ZIOPHARM Oncology, Inc. and Reminds Investors with Losses to Contact the Firm

Business Wire July 20, 2016

ZIOPHARM Issues Statement Clarifying Speculation on Financing Activity

GlobeNewswire July 20, 2016

ZIOPHARM Provides Update Regarding Phase I Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer

GlobeNewswire July 19, 2016

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces an Investigation of ZIOPHARM Oncology, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire July 18, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Into Possible Securities Fraud Violations by Certain Officers and Directors of ZIOPHARM Oncology, Inc.

Business Wire July 18, 2016

IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces An Investigation of Claims Against ZIOPHARM Oncology, Inc. And Advises Investors With Losses To Contact The Firm

Business Wire July 15, 2016

Federman & Sherwood Investigates ZIOPHARM Oncology, Inc. for Possible Violations of Federal Securities Laws

Business Wire July 15, 2016

Mid-Day Market Update: U.S. Stocks Turn Lower; Iteris Shares Climb Following Q1 Sales Outlook

Benzinga.com July 15, 2016

How Some ZIOP Buyers Got Screwed On Thursday Night

Benzinga.com July 15, 2016

ZIOPHARM Issues Statement Regarding Phase I Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer

GlobeNewswire July 15, 2016

12 Stocks Moving In Friday's Pre-Market Session

Benzinga.com July 15, 2016

ZIOPHARM Announces Plans for Phase I Clinical Trial with CD33 CAR-T Cell Therapy Targeting Acute Myeloid Leukemia

GlobeNewswire July 12, 2016

Intrexon and ZIOPHARM Amend Exclusive Channel Collaborations to Improve Alignment as Programs Advance through Development

GlobeNewswire June 30, 2016

ZIOPHARM Completes Enrollment in Second Patient Cohort and Initiates Enrollment in Third Cohort in Phase 1 Study of Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer

GlobeNewswire June 27, 2016

ZIOPHARM to Present at the Jefferies 2016 Healthcare Conference

GlobeNewswire June 2, 2016

ZIOPHARM Announces Clinical Data Highlighting Favorable Interim Survival Results with Gene Therapy Candidate Ad-RTS-hIL-12 in Brain Cancer

GlobeNewswire May 18, 2016

ZIOPHARM Reports First-Quarter 2016 Financial Results and Provides Update on Recent Activities

GlobeNewswire May 10, 2016

LDR Holding Corporation Reports First Quarter 2016 Results

GlobeNewswire May 10, 2016

ZIOPHARM Announces Two Oral Presentations at ASGCT 19th Annual Meeting

GlobeNewswire April 18, 2016